aztreonam has been researched along with Digestive System Disorders in 2 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bosi, A | 1 |
| Fanci, R | 1 |
| Pecile, P | 1 |
| Guidi, S | 1 |
| Saccardi, R | 1 |
| Vannucchi, AM | 1 |
| Longo, G | 1 |
| Donnini, E | 1 |
| Orsi, A | 1 |
| Rossi-Ferrini, P | 1 |
| Mozzillo, N | 1 |
| Formato, A | 1 |
| Quarto, G | 1 |
| Ottaviano, A | 1 |
| Romano, A | 1 |
2 trials available for aztreonam and Digestive System Disorders
| Article | Year |
|---|---|
Aztreonam versus colistin-neomycin for selective decontamination of the digestive tract in patients undergoing bone marrow transplantation: a randomized study.
Topics: Aztreonam; Bone Marrow Transplantation; Colistin; Digestive System Diseases; Drug Therapy, Combinati | 1992 |
To assess the efficacy of prophylaxis in digestive tract surgery using a predictive model of complication risk.
Topics: Aztreonam; Bacterial Infections; Chi-Square Distribution; Digestive System Diseases; Double-Blind Me | 1990 |